StonvexLoading…
StonvexStonvexStonvexCore line items from BAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $11.24B | $10.64B | $2.70B | $2.69B |
Operating Income | $-308.00M | $14.00M | Not available | Not available |
Net Income | $-957.00M | $-649.00M | $140.00M | $-314.00M |
EPS (Diluted) | $-1.87 | $-1.27 | $0.27 | $-0.62 |
Total Assets | $20.05B | $25.78B | Not available | Not available |
Total Liabilities | $13.95B | $18.76B | Not available | Not available |
Cash & Equivalents | $1.97B | $1.76B | Not available | Not available |
Free Cash Flow OCF − CapEx | $332.00M | $573.00M | Not available | Not available |
Shares Outstanding | 513.00M | 510.00M | Not available | Not available |